Literature DB >> 28801236

Frailty Status in Older Adults Is Related to Alterations in Indoleamine 2,3-Dioxygenase 1 and Guanosine Triphosphate Cyclohydrolase I Enzymatic Pathways.

Diego Marcos-Pérez1, María Sánchez-Flores1, Ana Maseda2, Laura Lorenzo-López2, José C Millán-Calenti2, Barbara Strasser3, Johanna M Gostner3, Dietmar Fuchs3, Eduardo Pásaro4, Vanessa Valdiglesias5, Blanca Laffon4.   

Abstract

BACKGROUND: Frailty is a multidimensional syndrome correlated to the loss of homeostasis and increased vulnerability to stressors, which is associated with increase in the risk of disability, comorbidity, hospitalization, and death in the elderly. It is based on the interplay of physiological, psychological, social, and environmental factors.
OBJECTIVES: Because aging involves a detrimental immune response, this work aimed to assess the possible role of chronic low-grade immune stimulation on frailty status in the elderly.
METHODS: Biomarkers involved in indoleamine 2,3-dioxygenase 1 and guanosine triphosphate cyclohydrolase I enzymatic pathways (namely neopterin, tryptophan, kynurenine, phenylalanine, tyrosine, and nitrite) were analyzed in a population of Spanish older adults aged 65 years and above, and their relationships with frailty status were evaluated.
RESULTS: Significant increases in neopterin levels, kynurenine/tryptophan ratio, and phenylalanine/tyrosine ratio, and significant decreases in tryptophan, nitrite and tyrosine concentrations in frail individuals compared with nonfrail persons were obtained. Significant correlations were also observed between immune biomarkers, indicating they change in parallel, thus, pointing to interrelated causes. Besides, reference ranges for a number of immune biomarkers in the population of robust older adults were established for the first time.
CONCLUSIONS: Results obtained in the present study are consistent with the idea that frailty status in the elderly is associated with an additional degree of immune stimulation, manifested in a more intense disturbance of indoleamine 2,3-dioxygenase 1 and guanosine triphosphate cyclohydrolase I pathways than in nonfrail or prefrail older adults.
Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frailty; immune activation; kynurenine/tryptophan ratio neopterin; nitrite; phenylalanine/tyrosine ratio

Mesh:

Substances:

Year:  2017        PMID: 28801236     DOI: 10.1016/j.jamda.2017.06.021

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  12 in total

1.  Interferon- Gamma- Inducible Guanosine Triphosphate Cyclohydrolase 1 (GTP-CH1) Pathway Is Associated with Frailty in Egyptian Elderly.

Authors:  Magda Mohamad; Somaia Ebeid; Mohamed Shawky Khater; Mohamad Alsadany
Journal:  Rep Biochem Mol Biol       Date:  2018-10

2.  Immunometabolism as predictor of frailty.

Authors:  Johanna M Gostner; Blanca Laffon; Thomas K Felder
Journal:  Aging (Albany NY)       Date:  2021-11-30       Impact factor: 5.682

3.  Specific Metabolites Involved in Antioxidation and Mitochondrial Function Are Correlated With Frailty in Elderly Men.

Authors:  Li Meng; Hong Shi; Da-Guang Wang; Jing Shi; Wen-Bin Wu; Ya-Min Dang; Guo-Qing Fan; Ji Shen; Pu-Lin Yu; Jun Dong; Rui-Yue Yang; Huan Xi
Journal:  Front Med (Lausanne)       Date:  2022-01-28

4.  Association Between Tryptophan Metabolites, Physical Performance, and Frailty in Older Persons.

Authors:  Ahmed Al Saedi; Sharron Chow; Sara Vogrin; Gilles J Guillemin; Gustavo Duque
Journal:  Int J Tryptophan Res       Date:  2022-01-31

5.  Frailty in Older Adults Is Associated With Plasma Concentrations of Inflammatory Mediators but Not With Lymphocyte Subpopulations.

Authors:  Diego Marcos-Pérez; María Sánchez-Flores; Ana Maseda; Laura Lorenzo-López; José C Millán-Calenti; Johanna M Gostner; Dietmar Fuchs; Eduardo Pásaro; Blanca Laffon; Vanessa Valdiglesias
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

6.  Kynurenines link chronic inflammation to functional decline and physical frailty.

Authors:  Reyhan Westbrook; Tae Chung; Jacqueline Lovett; Chris Ward; Humberto Joca; Huanle Yang; Mohammed Khadeer; Jing Tian; Qian-Li Xue; Anne Le; Luigi Ferrucci; Ruin Moaddel; Rafa de Cabo; Ahmet Hoke; Jeremy Walston; Peter M Abadir
Journal:  JCI Insight       Date:  2020-08-20

7.  Metabolites Associated with Vigor to Frailty Among Community-Dwelling Older Black Men.

Authors:  Megan M Marron; Tamara B Harris; Robert M Boudreau; Clary B Clish; Steven C Moore; Rachel A Murphy; Venkatesh L Murthy; Jason L Sanders; Ravi V Shah; George C Tseng; Stacy G Wendell; Joseph M Zmuda; Anne B Newman
Journal:  Metabolites       Date:  2019-04-30

8.  Identification of a Circulating Amino Acid Signature in Frail Older Persons with Type 2 Diabetes Mellitus: Results from the Metabofrail Study.

Authors:  Riccardo Calvani; Leocadio Rodriguez-Mañas; Anna Picca; Federico Marini; Alessandra Biancolillo; Olga Laosa; Laura Pedraza; Jacopo Gervasoni; Aniello Primiano; Giorgia Conta; Isabelle Bourdel-Marchasson; Sophie C Regueme; Roberto Bernabei; Emanuele Marzetti; Alan J Sinclair; Giovanni Gambassi
Journal:  Nutrients       Date:  2020-01-12       Impact factor: 5.717

Review 9.  Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies.

Authors:  Lijie Zhai; April Bell; Erik Ladomersky; Kristen L Lauing; Lakshmi Bollu; Jeffrey A Sosman; Bin Zhang; Jennifer D Wu; Stephen D Miller; Joshua J Meeks; Rimas V Lukas; Eugene Wyatt; Lynn Doglio; Gary E Schiltz; Robert H McCusker; Derek A Wainwright
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 8.786

10.  Exploring Early Detection of Frailty Syndrome in Older Adults: Evaluation of Oxi-Immune Markers, Clinical Parameters and Modifiable Risk Factors.

Authors:  Armanda Teixeira-Gomes; Blanca Laffon; Vanessa Valdiglesias; Johanna M Gostner; Thomas Felder; Carla Costa; Joana Madureira; Dietmar Fuchs; João Paulo Teixeira; Solange Costa
Journal:  Antioxidants (Basel)       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.